Amedica Corporation (Amda) Product Pipeline Analysis, 2016 Update - Share and Size Analysis

Amedica Corporation (AMDA) - Product Pipeline Analysis, 2016 Update –

Size, Share, Analysis, Forecast, Trends And Growth Report

Summary

Amedica Corporation (Amedica) is a biomaterial company. It develops, manufactures and

markets medical-grade silicon nitride ceramics for spinal and arthroplasty applications. The

company's products include Interbody fusion devices, pedicle screw systems, facet fixation

systems and others. Amedica also offers non-silicon nitride spinal fusion products which are

used for the treatment of deformity and degenerative spinal procedures. It serves surgeons,

hospitals and others. The company distributes its products through a network of independent

sales distributors and OEM partnerships in the US, Europe and South America. Amedica is

headquartered in Salt Lake City, Utah, the US. The company seeks to enhance its business

through the development and distribution of its proprietary Silicon Nitride Ceramic materials in

the orthopedic, spine and dental markets.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio

of pipeline products. The report provides key information about the company, its major products

and brands.

The report enhances decision making capabilities and help to create effective counter strategies

to gain competitive advantage.

Browse the full “Amedica Corporation Market” report at:

http://www.radiantinsights.com/research/amedica-corporation-amda-product-pipelineanalysis-2016-update

Scope:

- The report reviews detailed company profile with information on business description, key

company facts, major products and services, key competitors, key employees, locations and

subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Amedica

Corporation

- The report provides pipeline analysis on all pipeline products of the company (by equipment

type, by indication, by development stage, and by trial status)...